Absence of gastrointestinal infections in a cohort of patients with Zollinger-Ellison syndrome and other acid hypersecretors receiving long-term acid suppression with lansoprazole
Open Access
- 28 May 2008
- journal article
- Published by Springer Nature in BMC Gastroenterology
- Vol. 8 (1), 18
- https://doi.org/10.1186/1471-230X-8-18
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Use of Acid-Suppressing Drugs and the Risk of Bacterial GastroenteritisClinical Gastroenterology and Hepatology, 2007
- Gastric Acid Control With Esomeprazole, Lansoprazole, Omeprazole, Pantoprazole, and Rabeprazole: A Five-Way Crossover StudyAmerican Journal of Gastroenterology, 2003
- Esomeprazole 40 mg Provides Improved Intragastric Acid Control as Compared with Lansoprazole 30 mg and Rabeprazole 20 mg in Healthy VolunteersDigestion, 2003
- Gastric acid suppression does not promote clostridial diarrhoea in the elderly.QJM: An International Journal of Medicine, 2000
- Effect of 7-Day Therapy with Different Doses of the Proton Pump Inhibitor Lansoprazole on the Intragastric pH in Healthy Human SubjectsScandinavian Journal of Gastroenterology, 1999
- Pharmacological aspects of acid secretionDigestive Diseases and Sciences, 1995
- Vagal effects on acid and pepsin secretion and serum gastrin in duodenal ulcer and controlsDigestive Diseases and Sciences, 1993
- Infective gastroenteritis and its relationship to reduced gastric acidityScandinavian Journal of Gastroenterology, 1985
- A comparison between intragastric titration and aspiration technique under basal conditions and after food or pentagastrin stimulationDigestive Diseases and Sciences, 1978
- Influence of Gastric Acidity on Bacterial and Parasitic Enteric InfectionsAnnals of Internal Medicine, 1973